Astellas Pharma EMEA operates in 40 countries across Europe, the Middle East and Africa, and is a regional business of Tokyo-based Astellas Pharma Inc.
Europe is a global centre of excellence in healthcare and Astellas is committed to supporting EMEA by working in partnership with local governments to ensure patients can benefit from our medicines.
The EMEA headquarters of Astellas brings the specialist knowledge required to ensure our research programmes and medicines meet the requirements of individual countries in which doctors and patients live – as well as the medical and regulatory organisations that support them.
Our hope is to change tomorrow. To improve the lives of men, women and children by providing innovative medicines in areas of health where there is urgent need for better treatments. Transplant recipients, patients fighting cancer, those with life-threatening infections – these are just some of the patients we are striving to help now and in the future through our single-minded focus on turning innovative science into medical solutions.
CHANGING TOMORROW™ is the ethos that guides everything that Astellas does, and is the measure by which we judge our success.
NPR/18/0045/APEL. February 2019